Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-11-19 Purchase |
2021-11-23 07:30 am |
Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director |
3,950 | $37.3 | $147,350 | 167,668 (Indirect Direct) |
View |
| 2021-11-18 Purchase |
2021-11-22 07:31 am |
Axsome Therapeutics Inc. | AXSM | Pizzie Nick CHIEF FINANCIAL OFFICER |
955 | $35.26 | $33,676 | 41,931 (Indirect Direct) |
View |
| 2021-11-18 Purchase |
2021-11-22 07:30 am |
Axsome Therapeutics Inc. | AXSM | Coleman Mark Director |
1,430 | $35.09 | $50,181 | 426,528 (Indirect Direct) |
View |
| 2021-11-17 Purchase |
2021-11-19 07:30 am |
Axsome Therapeutics Inc. | AXSM | Saad Mark E Director |
3,300 | $34.52 | $113,922 | 10,102 (Indirect Direct) |
View |
| 2021-05-12 Purchase |
2021-05-13 07:05 am |
Axsome Therapeutics Inc. | AXSM | Coleman Mark Director |
500 | $58.15 | $29,075 | 425,098 (Indirect Direct) |
View |
| 2020-06-29 Purchase |
2020-06-30 08:20 am |
Axsome Therapeutics Inc. | AXSM | Coleman Mark Director |
650 | $78.5 | $51,025 | 408,798 (Indirect Direct) |
View |
| 2020-06-29 Purchase |
2020-06-30 08:19 am |
Axsome Therapeutics Inc. | AXSM | Pizzie Nick Chief Financial Officer |
777 | $76.64 | $59,549 | 41,277 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-03-02 Option Award |
2023-03-06 6:13 pm |
2023-03-02 2033-03-01 |
Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director |
2,082 | $0 | 2,082 (Direct) |
View |
| 2023-03-02 Option Award |
2023-03-06 6:12 pm |
2023-03-02 2033-03-01 |
Axsome Therapeutics Inc. | AXSM | Saad Mark E Director |
2,224 | $0 | 2,224 (Direct) |
View |
| 2023-01-03 Exercise |
2023-01-04 4:11 pm |
2013-03-22 2023-03-21 |
Axsome Therapeutics Inc. | AXSM | Coleman Mark Director |
17,501 | $0 | 447,525 (Direct) |
View |
| 2023-01-03 Exercise |
2023-01-04 4:11 pm |
N/A N/A |
Axsome Therapeutics Inc. | AXSM | Coleman Mark Director |
17,501 | $1.3 | 447,525 (Direct) |
View |
Ownership |
2022-06-15 4:31 pm |
N/A 2031-12-13 |
Axsome Therapeutics Inc. | AXSM | Murdock Hunter R. General Counsel |
0 | $0 | 142,335 (Direct) |
View |
| 2022-06-03 Option Award |
2022-06-07 4:08 pm |
2023-06-03 2032-06-03 |
Axsome Therapeutics Inc. | AXSM | Saad Mark E Director |
16,976 | $0 | 16,976 (Direct) |
View |
| 2022-06-03 Option Award |
2022-06-07 4:07 pm |
2023-06-03 2032-06-03 |
Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director |
16,976 | $0 | 16,976 (Direct) |
View |
| 2022-06-03 Option Award |
2022-06-07 4:07 pm |
2023-06-03 2032-06-03 |
Axsome Therapeutics Inc. | AXSM | Coleman Mark Director |
16,976 | $0 | 16,976 (Direct) |
View |
| 2022-03-15 Exercise |
2022-03-17 07:05 am |
2013-03-22 2023-03-21 |
Axsome Therapeutics Inc. | AXSM | Coleman Mark Director |
3,496 | $0 | 447,525 (Direct) |
View |
| 2022-03-15 Exercise |
2022-03-17 07:05 am |
N/A N/A |
Axsome Therapeutics Inc. | AXSM | Coleman Mark Director |
3,496 | $1.3 | 447,525 (Direct) |
View |
| 2022-03-04 Option Award |
2022-03-08 5:04 pm |
N/A 2032-03-03 |
Axsome Therapeutics Inc. | AXSM | TABUTEAU HERRIOT CHIEF EXECUTIVE OFFICER 10% Owner |
320,516 | $0 | 320,516 (Direct) |
View |
| 2022-03-04 Option Award |
2022-03-08 5:03 pm |
N/A 2032-03-03 |
Axsome Therapeutics Inc. | AXSM | Jacobson Mark L. CHIEF OPERATING OFFICER |
137,395 | $0 | 137,395 (Direct) |
View |
| 2022-03-04 Option Award |
2022-03-08 5:02 pm |
N/A 2032-03-03 |
Axsome Therapeutics Inc. | AXSM | Pizzie Nick CHIEF FINANCIAL OFFICER |
119,048 | $0 | 119,048 (Direct) |
View |
| 2022-03-04 Option Award |
2022-03-08 5:00 pm |
2022-03-04 2032-03-03 |
Axsome Therapeutics Inc. | AXSM | Coleman Mark Director |
2,798 | $0 | 2,798 (Direct) |
View |
| 2022-03-04 Option Award |
2022-03-08 5:00 pm |
2022-03-04 2032-03-03 |
Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director |
2,347 | $0 | 2,347 (Direct) |
View |
| 2022-03-04 Option Award |
2022-03-08 5:00 pm |
2022-03-04 2032-03-03 |
Axsome Therapeutics Inc. | AXSM | Saad Mark E Director |
2,337 | $0 | 2,337 (Direct) |
View |
| 2021-11-12 Option Award |
2021-11-15 7:55 pm |
N/A 2031-11-11 |
Axsome Therapeutics Inc. | AXSM | Pizzie Nick CHIEF FINANCIAL OFFICER |
36,086 | $0 | 36,086 (Direct) |
View |
| 2021-11-12 Option Award |
2021-11-15 7:54 pm |
N/A 2031-11-11 |
Axsome Therapeutics Inc. | AXSM | Jacobson Mark L. CHIEF OPERATING OFFICER |
41,638 | $0 | 41,638 (Direct) |
View |
| 2021-06-04 Option Award |
2021-06-08 4:52 pm |
2022-06-04 2031-06-04 |
Axsome Therapeutics Inc. | AXSM | Saad Mark E Director |
7,325 | $0 | 7,325 (Direct) |
View |
| 2021-06-04 Option Award |
2021-06-08 4:52 pm |
2022-06-04 2031-06-04 |
Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director |
7,325 | $0 | 7,325 (Direct) |
View |
| 2021-06-04 Option Award |
2021-06-08 4:51 pm |
2022-06-04 2031-06-04 |
Axsome Therapeutics Inc. | AXSM | Coleman Mark Director |
7,325 | $0 | 7,325 (Direct) |
View |
| 2021-03-05 Option Award |
2021-03-09 9:48 pm |
N/A 2031-03-04 |
Axsome Therapeutics Inc. | AXSM | Pizzie Nick Chief Financial Officer |
55,294 | $0 | 55,294 (Direct) |
View |
| 2021-03-05 Option Award |
2021-03-09 9:47 pm |
2021-03-05 2031-03-04 |
Axsome Therapeutics Inc. | AXSM | Saad Mark E Director |
1,241 | $0 | 1,241 (Direct) |
View |
| 2021-03-05 Option Award |
2021-03-09 9:46 pm |
N/A 2031-03-04 |
Axsome Therapeutics Inc. | AXSM | Jacobson Mark L. Chief Operating Officer |
63,801 | $0 | 63,801 (Direct) |
View |
| 2021-03-05 Option Award |
2021-03-09 9:45 pm |
N/A 2031-03-04 |
Axsome Therapeutics Inc. | AXSM | TABUTEAU HERRIOT CHIEF EXECUTIVE OFFICER 10% Owner |
148,870 | $0 | 148,870 (Direct) |
View |
| 2021-03-05 Option Award |
2021-03-09 9:45 pm |
2021-03-05 2031-03-04 |
Axsome Therapeutics Inc. | AXSM | Coleman Mark Director |
1,201 | $0 | 1,201 (Direct) |
View |
| 2021-03-05 Option Award |
2021-03-09 9:45 pm |
2021-03-05 2031-03-04 |
Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director |
1,463 | $0 | 1,463 (Direct) |
View |
| 2020-08-19 Gift |
2020-08-20 8:43 pm |
N/A N/A |
Axsome Therapeutics Inc. | AXSM | Coleman Mark Director |
397,998 | $0 | 408,798 (Direct) |
View |
| 2020-06-05 Option Award |
2020-06-05 6:42 pm |
2021-06-05 2030-06-05 |
Axsome Therapeutics Inc. | AXSM | Saad Mark E Director |
13,000 | $0 | 13,000 (Direct) |
View |
| 2020-06-05 Option Award |
2020-06-05 6:41 pm |
2021-06-05 2030-06-05 |
Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director |
13,000 | $0 | 13,000 (Direct) |
View |
| 2020-06-05 Option Award |
2020-06-05 6:40 pm |
2021-06-05 2030-06-05 |
Axsome Therapeutics Inc. | AXSM | Coleman Mark Director |
13,000 | $0 | 13,000 (Direct) |
View |